A citation-based method for searching scientific literature

S Jordan, J L Eberling, K S Bankiewicz, D Rosenberg, P G Coxson, H F VanBrocklin, J P O'Neil, M E Emborg, W J Jagust. Brain Res 1997
Times Cited: 56







List of co-cited articles
368 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
K S Bankiewicz, E H Oldfield, C C Chiueh, J L Doppman, D M Jacobowitz, I J Kopin. Life Sci 1986
265
26

A novel MPTP primate model of Parkinson's disease: neurochemical and clinical changes.
J L Eberling, W J Jagust, S Taylor, J Bringas, P Pivirotto, H F VanBrocklin, K S Bankiewicz. Brain Res 1998
33
39

4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography.
W P Melega, M M Perlmutter, A Luxen, C H Nissenson, S T Grafton, S C Huang, M E Phelps, J R Barrio. J Neurochem 1989
48
25


Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices.
B D Pate, T Kawamata, T Yamada, E G McGeer, K A Hewitt, B J Snow, T J Ruth, D B Calne. Ann Neurol 1993
148
17


Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.
J R Barrio, S C Huang, D C Yu, W P Melega, J Quintana, S R Cherry, A Jacobson, M Namavari, N Satyamurthy, M E Phelps. J Cereb Blood Flow Metab 1996
33
27

PET studies of functional compensation in a primate model of Parkinson's disease.
J L Eberling, K S Bankiewicz, S Jordan, H F VanBrocklin, W J Jagust. Neuroreport 1997
38
23

Evaluation of dopaminergic presynaptic integrity: 6-[18F]fluoro-L-dopa versus 6-[18F]fluoro-L-m-tyrosine.
D J Doudet, G L Chan, S Jivan, O T DeJesus, E G McGeer, C English, T J Ruth, J E Holden. J Cereb Blood Flow Metab 1999
30
30

A new precursor for the preparation of 6-[18F]Fluoro-L-m-tyrosine ([18F]FMT): efficient synthesis and comparison of radiolabeling.
Henry F VanBrocklin, Milen Blagoev, Alexander Hoepping, James P O'Neil, Manuela Klose, Pius A Schubiger, Simon Ametamey. Appl Radiat Isot 2004
26
34

Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: biochemical changes in striatal regions.
J D Elsworth, A Y Deutch, D E Redmond, J R Taylor, J R Sladek, R H Roth. Neuroscience 1989
121
14

Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach.
K S Bankiewicz, J L Eberling, M Kohutnicka, W Jagust, P Pivirotto, J Bringas, J Cunningham, T F Budinger, J Harvey-White. Exp Neurol 2000
284
14

Synthesis of 6-[18F] and 4-[18F]fluoro-L-m-tyrosines via regioselective radiofluorodestannylation.
M Namavari, N Satyamurthy, M E Phelps, J R Barrio. Appl Radiat Isot 1993
29
24

Nigrostriatal function in humans studied with positron emission tomography.
W R Martin, M R Palmer, C S Patlak, D B Calne. Ann Neurol 1989
281
12

Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys.
M E Emborg, S Y Ma, E J Mufson, A I Levey, M D Taylor, W D Brown, J E Holden, J H Kordower. J Comp Neurol 1998
212
12

Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys.
J L Eberling, P Pivirotto, J Bringas, K S Bankiewicz. Exp Neurol 2000
18
38


Affinities of dopamine analogs for monoamine granular and plasma membrane transporters: implications for PET dopamine studies.
C J Endres, S Swaminathan, O T DeJesus, M Sievert, A E Ruoho, D Murali, S G Rommelfanger, J E Holden. Life Sci 1997
20
30

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.
D J Doudet, G L Chan, J E Holden, E G McGeer, T A Aigner, R J Wyatt, T J Ruth. Synapse 1998
59
10


6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.
D J Doudet, H Miyake, R T Finn, C A McLellan, T G Aigner, R Q Wan, H R Adams, R M Cohen. Exp Brain Res 1989
46
13

Simplified reference tissue model for PET receptor studies.
A A Lammertsma, S P Hume. Neuroimage 1996
10

The ECAT EXACT HR: performance of a new high resolution positron scanner.
K Wienhard, M Dahlbom, L Eriksson, C Michel, T Bruckbauer, U Pietrzyk, W D Heiss. J Comput Assist Tomogr 1994
439
10

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H Bernheimer, W Birkmayer, O Hornykiewicz, K Jellinger, F Seitelberger. J Neurol Sci 1973
10

Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
G C Davis, A C Williams, S P Markey, M H Ebert, E D Caine, C M Reichert, I J Kopin. Psychiatry Res 1979
10

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.
J W Langston, P Ballard, J W Tetrud, I Irwin. Science 1983
10

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.
Steven S Gill, Nikunj K Patel, Gary R Hotton, Karen O'Sullivan, Renée McCarter, Martin Bunnage, David J Brooks, Clive N Svendsen, Peter Heywood. Nat Med 2003
905
10

Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
Krystof S Bankiewicz, John Forsayeth, Jamie L Eberling, Rosario Sanchez-Pernaute, Philip Pivirotto, John Bringas, Peter Herscovitch, Richard E Carson, William Eckelman, Bryan Reutter,[...]. Mol Ther 2006
200
10

Focal striatal dopamine may potentiate dyskinesias in parkinsonian monkeys.
Krystof S Bankiewicz, Marcel Daadi, Philip Pivirotto, John Bringas, Laura Sanftner, Janet Cunningham, John R Forsayeth, Jamie L Eberling. Exp Neurol 2006
42
14

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease.
J L Eberling, W J Jagust, C W Christine, P Starr, P Larson, K S Bankiewicz, M J Aminoff. Neurology 2008
248
10

The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.
L Wahl, R Chirakal, G Firnau, E S Garnett, C Nahmias. J Cereb Blood Flow Metab 1994
45
11

Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
V Dhawan, T Ishikawa, C Patlak, T Chaly, W Robeson, A Belakhlef, C Margouleff, F Mandel, D Eidelberg. J Nucl Med 1996
47
10

Distribution and kinetics of 3-O-methyl-6-[18F]fluoro-L-dopa in the rhesus monkey brain.
D J Doudet, C A McLellan, R Carson, H R Adams, H Miyake, T G Aigner, R T Finn, R M Cohen. J Cereb Blood Flow Metab 1991
51
9

Dopamine visualized in the basal ganglia of living man.
E S Garnett, G Firnau, C Nahmias. Nature 1983
436
8


Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
U Wüllner, P Pakzaban, A L Brownell, P Hantraye, L Burns, T Shoup, D Elmaleh, A J Petto, R D Spealman, G L Brownell. Exp Neurol 1994
42
11

A methodology for specifying PET VOI's using multimodality techniques.
G J Klein, X Teng, W J Jagust, J L Eberling, A Acharya, B W Reutter, R H Huesman. IEEE Trans Med Imaging 1997
28
17



Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo.
O T Dejesus, C J Endres, S E Shelton, R J Nickles, J E Holden. Synapse 2001
30
16


Age-related cognitive deficits mediated by changes in the striatal dopamine system.
L Bäckman, N Ginovart, R A Dixon, T B Wahlin, A Wahlin, C Halldin, L Farde. Am J Psychiatry 2000
301
8

A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
John R Forsayeth, Jamie L Eberling, Laura M Sanftner, Zhu Zhen, Philip Pivirotto, John Bringas, Janet Cunningham, Krystof S Bankiewicz. Mol Ther 2006
73
8

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.
O Mawlawi, D Martinez, M Slifstein, A Broft, R Chatterjee, D R Hwang, Y Huang, N Simpson, K Ngo, R Van Heertum,[...]. J Cereb Blood Flow Metab 2001
433
8

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data.
Vesna Sossi, Raúl de La Fuente-Fernández, James E Holden, Doris J Doudet, Jess McKenzie, A J Stoessl, T J Ruth. J Cereb Blood Flow Metab 2002
88
8

Relationship of striatal dopamine synthesis capacity to age and cognition.
Meredith N Braskie, Claire E Wilcox, Susan M Landau, James P O'Neil, Suzanne L Baker, Cindee M Madison, Jennifer T Kluth, William J Jagust. J Neurosci 2008
63
8

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
B J Snow, I Tooyama, E G McGeer, T Yamada, D B Calne, H Takahashi, H Kimura. Ann Neurol 1993
270
7



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.